(Yakup Shinmoon)
On Feb 1, Chong Kun Dang Pharmaceutical Corp. launched self-developed the nation's first diabetes treatment 'Duvie'.
'Duvie' (ingredient: lobeglitazone sulfate) is the second new drug of CKD, followed by chemotherapy agent 'Camtobell' (2003). 'Duvie' has been developed since 2000, and it received new drug approval in July 2013.
It is a glitazone-type drug to treat pa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.